HIV vaccine (influenza virus carrier) (Polymun/Lionex)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHIV vaccine (influenza virus carrier) (Polymun/Lionex)
Drug Alias NameEN41-FPA2 (Polymun/Lionex)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionTransmembrane glycoprotein gp41 modulators
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPolymun Scientific Immunobiologische Forschung GmbH
China Registration ClassN/A

Develop Information

Active CompaniesPolymun Scientific Immunobiologische Forschung GmbHLionex Diagnostics And Therapeutics
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A